Data presented at key congresses in North America and EuropeCAMBRIDGE, United Kingdom, Feb. 21, 2025 (GLOBE NEWSWIRE) -- ...

The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

[5] After exclusions of such diseases as infectious colitis, bacillary dysentery, amebiasis, chronic schistosomiasis, intestinal tuberculosis, Crohn's disease, ischemic colitis and radiation ...

FFPE human tissue samples, with corresponding anonymised clinical data, were obtained from St Mark’s Hospital from patients with extensive ulcerative colitis (Montreal Classification E3). All ...

Dr K Geboes, Department of Pathology, University Hospital, KULeuven, Minderbroedersstraat 12, 3000 Leuven, Belgium. Email: Karel.Geboes{at}uz.kuleuven.ac.be BACKGROUND Evaluation of histological ...

Ulcerative colitis (UC), characterized by disrupted intestinal barrier ... confers multi-target protective effects in experimental colitis and associated hepatic pathology, warranting further ...

Other comorbidities that could justify the pathology. • Other drugs/ toxics that ... A differential diagnosis should also be considered with IBD [Ulcerative colitis/Chron’s Disease (UC/CD)], as ...

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s diseaseNew detailed data from the RELIEVE UCCD ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

"There is a pressing need to modernize traditional endoscopic assessments in IBD to enhance precision and efficiency in ulcerative colitis research," said Mark Genovese, MD, Senior Vice President of ...